US$ 23.03
glp-1 news oct 16 2025 Who Gets the Shot? Access by State GLP-1 in three charts: sticky
Description
That number should alarm you

Nikolaidis, L
Finan B, Yang B, Ottaway N, et al
Such mechanisms involve ischemic coronary artery disease, hypertension, or valvular disease, leading to cardiac hypertrophy and fibrosis

Judicial Panel for Multidistrict Litigation (JPML) formed another GLP-1 MDL, transferring cases involving claims of NAION (non-arteritic anterior ischemic optic neuropathy) to an MDL named In Re: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Non-Arteritic Anterior Ischemic Optic Neuropathy Products Liability Litigation, MDL 3163
